Dr. Larsen has a wide-range of experience in the discovery, research and development of biologics, small molecule therapeutics and drug delivery medical devices. He is the CEO and co-founder of Aquinnah Pharmaceuticals, a pharmaceutical company focused on the development of treatments for neurodegenerative diseases.
Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
More articles on devices:
5 quick notes on Precision Spine’s MD-Max ULIF System: Dr. Donald Kucharzyk
LDR’s 4Q revenue up 23.6%: 12 key notes
Orthocell’s expands Asia presence; tendon repair therapy used in Hong Kong
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
